Daiwa Securities Group
AVXL icon

Daiwa Securities Group’s Anavex Life Sciences AVXL Stock Holding History

Daiwa Securities Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-314
Closed -$1K – 1215
2025
Q4 		$1K Hold
314
– – ﹤0.01% 1341
2025
Q3 		$3K Hold
314
– – ﹤0.01% 1236
2025
Q2 		$3K Hold
314
– – ﹤0.01% 1187
2025
Q1 		$3K Hold
314
– – ﹤0.01% 1160
2024
Q4 		$3K Hold
314
– – ﹤0.01% 1187
2024
Q3 		$2K Hold
314
– – ﹤0.01% 1213
2024
Q2 		$1K Hold
314
– – ﹤0.01% 1283
2024
Q1 		$2K Hold
314
– – ﹤0.01% 1260
2023
Q4 		$3K Hold
314
– – ﹤0.01% 1240
2023
Q3 		$2K Hold
314
– – ﹤0.01% 1212
2023
Q2 		$3K Hold
314
– – ﹤0.01% 1214
2023
Q1 		$3K Hold
314
– – ﹤0.01% 1177
2022
Q4 		$3K Buy
314
+92
+41% +$983 ﹤0.01% 1187
2022
Q3 		$2K Hold
222
– – ﹤0.01% 1217
2022
Q2 		$2K Hold
222
– – ﹤0.01% 1224
2022
Q1 		$3K Hold
222
– – ﹤0.01% 1210
2021
Q4 		$4K Buy
+222
New +$4.22K ﹤0.01% 1214

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Daiwa Securities Group's AVXL Position: Q1 2026 in Review

Daiwa Securities Group sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 314 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in AVXL in Q4 2021 and held it in 17 quarters. The position peaked at $4K in Q4 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Daiwa Securities Group reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 314 Anavex Life Sciences shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Anavex Life Sciences in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Anavex Life Sciences position peaked at $4K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.